Schrodinger (NASDAQ:SDGR - Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data before the market opens on Wednesday, July 30th. Analysts expect the company to announce earnings of ($0.83) per share and revenue of $52.03 million for the quarter. Schrodinger has set its FY 2025 guidance at EPS.
Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.82) EPS for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrodinger had a negative net margin of 83.39% and a negative return on equity of 44.74%. The business had revenue of $59.55 million during the quarter, compared to analyst estimates of $54.60 million. During the same quarter last year, the company posted ($0.86) earnings per share. The company's revenue was up 62.7% on a year-over-year basis. On average, analysts expect Schrodinger to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Schrodinger Price Performance
SDGR traded down $0.26 on Friday, hitting $22.23. 759,979 shares of the stock were exchanged, compared to its average volume of 1,134,198. Schrodinger has a 12 month low of $16.60 and a 12 month high of $28.47. The business has a 50-day moving average of $21.86 and a two-hundred day moving average of $22.48. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of -8.45 and a beta of 1.58.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Schrodinger stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 4.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,055 shares of the company's stock after purchasing an additional 1,412 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Schrodinger were worth $653,000 as of its most recent SEC filing. Institutional investors own 79.05% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently weighed in on SDGR shares. Morgan Stanley started coverage on shares of Schrodinger in a research report on Thursday, July 3rd. They set an "equal weight" rating and a $28.00 price objective for the company. KeyCorp dropped their target price on shares of Schrodinger from $32.00 to $30.00 and set an "overweight" rating for the company in a report on Monday, July 14th.
Get Our Latest Report on SDGR
Schrodinger Company Profile
(
Get Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Read More

Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.